Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

Bibliographic Details
Main Authors: David R. Minor, Samantha P. Moores, John K. Chan
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578917301017
_version_ 1819161754689601536
author David R. Minor
Samantha P. Moores
John K. Chan
author_facet David R. Minor
Samantha P. Moores
John K. Chan
author_sort David R. Minor
collection DOAJ
first_indexed 2024-12-22T17:17:22Z
format Article
id doaj.art-af8d999c479945f68b1ff8f076261778
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-12-22T17:17:22Z
publishDate 2017-11-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-af8d999c479945f68b1ff8f0762617782022-12-21T18:18:55ZengElsevierGynecologic Oncology Reports2352-57892017-11-0122C434410.1016/j.gore.2017.09.009Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancerDavid R. Minor0Samantha P. Moores1John K. Chan2California Pacific Medical Center Research Institute, 2200 Webster St. Suite 511, San Francisco, CA 94115, United StatesCalifornia Pacific Medical Center Research Institute, 2200 Webster St., San Francisco, CA 94115, United StatesCalifornia Pacific Medical Center Research Institute/Palo Alto Medical Foundation, 3838 California St., San Francisco, CA 94118, United Stateshttp://www.sciencedirect.com/science/article/pii/S2352578917301017
spellingShingle David R. Minor
Samantha P. Moores
John K. Chan
Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
Gynecologic Oncology Reports
title Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_full Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_fullStr Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_full_unstemmed Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_short Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_sort prolonged survival after intraperitoneal interleukin 2 immunotherapy for recurrent ovarian cancer
url http://www.sciencedirect.com/science/article/pii/S2352578917301017
work_keys_str_mv AT davidrminor prolongedsurvivalafterintraperitonealinterleukin2immunotherapyforrecurrentovariancancer
AT samanthapmoores prolongedsurvivalafterintraperitonealinterleukin2immunotherapyforrecurrentovariancancer
AT johnkchan prolongedsurvivalafterintraperitonealinterleukin2immunotherapyforrecurrentovariancancer